Medicine and Dentistry
Pancreas Cancer
100%
Colorectal Cancer
57%
Irreversible Electroporation
57%
Surgery
57%
D-Dimer
38%
Pancreas Adenocarcinoma
38%
Prospective Cohort Study
38%
Overall Survival
32%
Neoplasm
27%
Ablation Therapy
23%
Biological Marker
19%
Spleen Injury
19%
Sigmoidoscopy
19%
Nociception
19%
Cohort Analysis
19%
Cancer Tissue
19%
Systematic Review
19%
Liver Metastasis
19%
Quality of Life
19%
Cell-Free DNA
19%
Proteomics
19%
Metastatic Carcinoma
13%
Mortality Rate
13%
Proportional Hazards Model
12%
Promoter Region
12%
Diseases
11%
Hazard Ratio
9%
Survival Analysis
7%
Pancreatic Ductal Adenocarcinoma
7%
Diagnosis
7%
Colonoscopy
6%
Diagnostic Procedure
6%
Pembrolizumab
6%
Immunotherapy
6%
Keyphrases
Statins
19%
Proteomics Characterization
19%
Cellular Models
19%
Splenic Injury
19%
Prognostic Efficacy
19%
Local Ablative Treatment
19%
Colorectal Cancer Cells
19%
Para-aortic Lymph Node
19%
Curative Resection
19%
Carcinoembryonic Antigen Levels
19%
Venous Resection
19%
Life Perceptions
19%
Cancer Effects
19%
Blood Measurements
19%
Registry Data
19%
DNA Promoter
12%
Blood Samples
12%
Imaging Endpoints
9%
Carcinoembryonic Antigen
8%
Colorectal Cancer Biomarkers
6%
Colorectal Carcinoma Cells
6%
NCM460
6%
SW480
6%
Carcinoma Cell Lines
6%
HCT116
6%
Top-down Proteomics
6%
S100A6
6%
Cab45
6%
S100A11
6%
HNRNPH2
6%
Biochemistry, Genetics and Molecular Biology
Pribnow Box
38%
Carcinoembryonic Antigen
22%
Prospective Cohort Study
19%
Tandem Mass Spectrometry
19%
FABP1
19%
GSTP1
19%
Two-Dimensional Gel Electrophoresis
19%
Western Blot
19%
Mass Spectrometry
19%
Polyacrylamide Gel Electrophoresis
19%
Proteomics
19%
DNA Methylation
19%
Liquid Chromatography-Mass Spectrometry
19%
D-Dimer
19%
Protein Expression
19%
Methylation
6%
S100A6
6%
Top-down Proteomics
6%
Cancer Screening
6%
Bottom-up Proteomics
6%